SIT DOWN BEFORE READING!
Jun. 20th, 2026 02:14 pmFDA ADVISORS APPROVED MODERNA'S mRNA FLU VACCINE!
This is the one that the White House tried to block from even being reviewed. It shows extreme efficacy, but of course runs afowl of Robert Fucking Kennedy Juniormint's agenda and attempt to destroy the vaccine industry to his personal profit.
From the article: "Data from a Phase 3 trial including over 40,000 adults age 50 and older found the mRNA vaccine was around 27 percent more effective against seasonal flu than a standard flu shot. A smaller Phase 3 trial, involving data from nearly 3,000 people age 65 years and older, showed the shot produces stronger immune responses than a high-dose flu vaccine, which is recommended for this age group. The safety profile of the vaccine was also generally good."
Nice! A more effective vaccine, that's always good! I turn 65 at the end of the year, and I was a little concerned about the concept of a higher-dose flu shot as I have a bit of a negative reaction to vaccinations. It's nothing more than being a little under the weather over the weekend with a mild fever, but if I can avoid it with a regular dose vaccine, all the better for me! And with the added bonus that the vaccine uses the same framework as their mRNA Covid vaccine, it is easy for them to reprogram it, giving them manufacturing flexibility to respond rapidly to changes in the flu virus.
This decision follows some drama from February, detailed from the article: "The outcome today is in stark contrast to a few months ago, when Trump official Vinay Prasad was overseeing vaccines at the FDA. In a shocking decision in February, Prasad rejected Moderna’s filing, refusing to even review the vaccine. Prasad claimed that the large vaccine trial was not “adequate and well-controlled” because it did not compare efficacy to a high-dose vaccine in people 65 and older. Instead, Moderna used the smaller trial to compare immune responses of mRNA-1010 to a high-dose vaccine—which was a plan the FDA had previously agreed would be acceptable.
Moderna was blindsided by the refusal, which Prasad issued over the objections of FDA scientists and career officials. Amid widespread outcry, the FDA reversed the decision the next week, agreeing to review the vaccine. Around the same time, Prasad was also behind the rejection of a closely watched gene therapy for Huntington’s disease made by UniQure, which was widely criticized and called “truly evil” by a former FDA official.
Prasad was pushed out of FDA at the end of April amid a string of decried decisions and controversies. Prasad’s decision on UniQure’s gene therapy was reversed on Wednesday."
This was a review panel decision which is not final FDA approval. However, with a unanimous panel approval, and the blow-back of the initial refusal to even consider the application by Prasad, it would be difficult for the FDA to not approve it when it comes up for final approval, a deadline has been set for August 5.
There is one additional step beyond that, and it is problematic: it must be reviewed by the Center for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP). And that committee currently does not exist.. A judge issued an injunction declaring all of the appointees to that committee by RFK had been appointed improperly. Approval by that committee is what gets insurance approval for vaccines. Once it's approved by the FDA and ACIP, Moderna says they can get their new flu vaccine out to market before the end of the year!
Now we wait....
https://arstechnica.com/health/2026/06/fda-advisors-unanimously-vote-to-approve-modernas-mrna-after-agency-drama/
This is the one that the White House tried to block from even being reviewed. It shows extreme efficacy, but of course runs afowl of Robert Fucking Kennedy Juniormint's agenda and attempt to destroy the vaccine industry to his personal profit.
From the article: "Data from a Phase 3 trial including over 40,000 adults age 50 and older found the mRNA vaccine was around 27 percent more effective against seasonal flu than a standard flu shot. A smaller Phase 3 trial, involving data from nearly 3,000 people age 65 years and older, showed the shot produces stronger immune responses than a high-dose flu vaccine, which is recommended for this age group. The safety profile of the vaccine was also generally good."
Nice! A more effective vaccine, that's always good! I turn 65 at the end of the year, and I was a little concerned about the concept of a higher-dose flu shot as I have a bit of a negative reaction to vaccinations. It's nothing more than being a little under the weather over the weekend with a mild fever, but if I can avoid it with a regular dose vaccine, all the better for me! And with the added bonus that the vaccine uses the same framework as their mRNA Covid vaccine, it is easy for them to reprogram it, giving them manufacturing flexibility to respond rapidly to changes in the flu virus.
This decision follows some drama from February, detailed from the article: "The outcome today is in stark contrast to a few months ago, when Trump official Vinay Prasad was overseeing vaccines at the FDA. In a shocking decision in February, Prasad rejected Moderna’s filing, refusing to even review the vaccine. Prasad claimed that the large vaccine trial was not “adequate and well-controlled” because it did not compare efficacy to a high-dose vaccine in people 65 and older. Instead, Moderna used the smaller trial to compare immune responses of mRNA-1010 to a high-dose vaccine—which was a plan the FDA had previously agreed would be acceptable.
Moderna was blindsided by the refusal, which Prasad issued over the objections of FDA scientists and career officials. Amid widespread outcry, the FDA reversed the decision the next week, agreeing to review the vaccine. Around the same time, Prasad was also behind the rejection of a closely watched gene therapy for Huntington’s disease made by UniQure, which was widely criticized and called “truly evil” by a former FDA official.
Prasad was pushed out of FDA at the end of April amid a string of decried decisions and controversies. Prasad’s decision on UniQure’s gene therapy was reversed on Wednesday."
This was a review panel decision which is not final FDA approval. However, with a unanimous panel approval, and the blow-back of the initial refusal to even consider the application by Prasad, it would be difficult for the FDA to not approve it when it comes up for final approval, a deadline has been set for August 5.
There is one additional step beyond that, and it is problematic: it must be reviewed by the Center for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP). And that committee currently does not exist.. A judge issued an injunction declaring all of the appointees to that committee by RFK had been appointed improperly. Approval by that committee is what gets insurance approval for vaccines. Once it's approved by the FDA and ACIP, Moderna says they can get their new flu vaccine out to market before the end of the year!
Now we wait....
https://arstechnica.com/health/2026/06/fda-advisors-unanimously-vote-to-approve-modernas-mrna-after-agency-drama/
